Lipoxins: A Novel Regulator in Embryo Implantation
Author(s) -
Jing Xiong,
Pan Zeng,
Duyun Ye
Publication year - 2011
Publication title -
the scientific world journal
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.453
H-Index - 93
eISSN - 2356-6140
pISSN - 1537-744X
DOI - 10.1100/tsw.2011.15
Subject(s) - regulator , endometrium , blastocyst , embryo , leukemia inhibitory factor , homeobox , inflammation , decidua , biology , medicine , pregnancy , bioinformatics , microbiology and biotechnology , embryogenesis , immunology , fetus , genetics , gene , transcription factor , placenta , interleukin 6
Embryo implantation is essential for mammalian pregnancy, which involves intricate cross-talk between the blastocyst and the maternal endometrium. Recent advances have identified various molecules crucial to implantation and endometrial receptivity, including leukemia inhibitory factor, calcitonin, and homeobox A10. There is a close relationship between implantation and inflammation. Lipoxins, important in the resolution of inflammation, may be a potential regulator in implantation. Here we discuss the hypothesis that lipoxins may work as a novel regulator in embryo implantation and the possible molecular mechanisms.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom